Which US region will have highest ZYN market penetration by end of 2025?
Northeast • 25%
Midwest • 25%
South • 25%
West • 25%
Market research reports or sales data from Philip Morris International
FDA Authorizes 20 ZYN Nicotine Pouches by Philip Morris International as Safer Alternative
Jan 16, 2025, 05:39 PM
The U.S. Food and Drug Administration (FDA) has authorized the marketing of 20 ZYN nicotine pouch products, marking the first time the agency has approved such products. Following an extensive scientific review, the FDA determined that these products pose a lower risk of cancer and other serious health conditions compared to cigarettes and most smokeless tobacco products. The authorization was granted through the premarket tobacco product application (PMTA) pathway, and the products, including 10 flavors such as coffee, mint, and menthol, are intended for adults who smoke cigarettes or use other smokeless tobacco products. Philip Morris International, through its Swedish Match unit, will market these products. The FDA will closely monitor youth use and the company's compliance with marketing restrictions to prevent underage use. Philip Morris International has agreed to implement measures to restrict youth access and appeal, such as not using mass-market advertising on radio and TV and employing actors/models no younger than 35 years old for marketing.
View original story
New York • 25%
Texas • 25%
California • 25%
Florida • 25%
Not in top 3 • 25%
3rd • 25%
2nd • 25%
1st • 25%
Midwest • 25%
South • 25%
Northeast • 25%
West • 25%
Adults aged 18-24 • 25%
Adults aged 45 and over • 25%
Adults aged 35-44 • 25%
Adults aged 25-34 • 25%
Rest of the World • 25%
Europe • 25%
Asia-Pacific • 25%
North America • 25%
3 mg • 25%
Equal sales • 25%
Other strengths (if introduced) • 25%
6 mg • 25%
Northeast • 25%
South • 25%
West Coast • 25%
Midwest • 25%
Adults aged 41-50 • 25%
Adults aged 51 and older • 25%
Adults aged 31-40 • 25%
Adults aged 21-30 • 25%
Increase • 25%
Significant reduction • 25%
Moderate reduction • 25%
No change • 25%
Yes • 50%
No • 50%
35-44 • 25%
45+ • 25%
18-24 • 25%
25-34 • 25%